Dr. Heiko Manninga

Dr. Heiko Manninga is Managing Director, CSO at NEUWAY Pharma leading R&D and related partnering. Dr. Manninga had been with the company since its inception and is supported by a team of 20 experts as well as staff including experienced consultants to complement the in-house experience. In only a year under his leadership, NEUWAY has built up the company and initiated several preclinical projects. Dr. Manninga also established a collaboration with a major pharma-ceutical partner and acquired additional public funding to support the further research program of NEUWAY Pharma.

Dr. Oliver Ernst

Dr. Ernst joined NEUWAY in November 2018 as managing director, also leading business development, strategic partnering and financing, with strong background in management of innovation and intellectual property. Prior to NEUWAY, Oliver had gained over ten years of professional experience in the field of intellectual property and innovation management ranging from private practice to large enterprise. Oliver graduated with a degree in biotechnology engineering from the Technical University Berlin and received his PhD at the Fraunhofer Institute for Biomedical Engineering (IBMT).